Back to search

Article

Comparing the efficacy of five first-line treatment regimens for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials

2023-04-25

Abstract excerpt

<h4>Background: </h4> To find ideal treatment regimens in unresectable hepatocellular carcinoma (u-HCC) are clinically important. This study evaluated the efficacy of five first-line regimens in u-HCC patients at 6-, 12-, 18-, 24-, and 30-month overall survival (OS) to provide reference for rational clinical treatment. <h4>Methods: </h4> We performed a systematic search using five databases. Screening and includi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e71be9b2-8f58-5746-8aa5-6163a0f22cb6
DOI
10.21203/rs.3.rs-2817825/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparing the efficacy of five first-line treatment regimens for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trialsDOI 10.21203/rs.3.rs-2817825/v1
Toripalimab combined with anlotinib as the second-line treatment for advanced hepatocellular carcinoma patients: a prospective, single arm phase II clinical studySemantic proximity
The Current State of Evaluation of Hepatocellular Carcinoma Differentiation and Treatment Response with Japanese Guidelines.Semantic proximity
Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocolSemantic proximity
Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort StudySemantic proximity
Causes of Death in Hepatocellular Carcinoma Patients: A SEER-Based StudySemantic proximity
First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma: a real-world studySemantic proximity
Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents.Semantic proximity
Comparison of Clinical Efficacy of Molecular Targeted Drugs Combined with Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemoembolization Alone for Primary Liver CancerSemantic proximity
Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screenSemantic proximity
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).Semantic proximity
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.Semantic proximity
Select a neighboring publication to make it the new centre.